The stock market indices had a tough session to start the week. It was a down day, for sure. The day opened down, they pulled back, popped, couldn’t get through the highs, and sold off to the morning lows and session lows by about 11-11:15 this morning. They then rallied midday, and could not get through the highs, rolled over, retested twice, but couldn’t break down as well. Enough damage had been done to create losses for the day.

Net on the day, the Dow was down 55.75 at 17,737.00. The S&P 500 was down 6.65 to 2066.13. The Nasdaq 100 was down 20.38 to 4511.70.

Advance-declines were nearly 3 to 1 negative on the New York Stock Exchange, and 3 to 2 negative on the Nasdaq. Up/down volume was 2 1/2 to 1 negative on New York, total volume of 3 1/2 billion shares traded. The Nasdaq traded 1 2/3 billion shares and had a 5 to 3 negative volume ratio.

TheTechTrader.com board was a mixed picture today. Priceline Inc. (PCLN) was down 17.94 to 1281.76, Google Inc. (GOOG) down 4.62 to 745.29, Amazon.com Inc. (AMZN) down 5.31 to 593.19, and Netflix, Inc. (NFLX) down 1.35 to 104.35. However, Apple gained 1.13 to 111.12.

Baidu, Inc. (BIDU) lost 1.36 to 188.97, Facebook, Inc. (FB) gave back 3.51 to 112.55, and First Solar, Inc. (FSLR) was down just 24 cents to 67.24.

Tesla Motors, Inc. (TSLA) jumped 9.40 to 246.90, after figures were released for the new model sales.

Other stocks of note to the upside included Stratasys Ltd. (SSYS), a new swing trade for us, up 2.25 to 27.65, Editas Medicine Inc. (EDIT) up 2.68 to 39.58, Bristol-Myers Squibb Company (BMY) 1.06 to 65.97, and ACADIA Pharmaceuticals Inc. (ACAD) 1.40 to 30.06, after reaching as high as 31.79.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) ran 1.00 to 30.97.

Checking the TheTechTrader.com percent-gain leaderboard, Sky440, Inc. (SKYF) was up 1.64 to 5.90, or 38 1/2%, on 18 million shares. Sorrento Therapeutics, Inc. (SRNE) climbed 85 cents to 6.30, or 16%, on over a half million shares. Genocea Biosciences, Inc. (GNCA) bounced 88 cents to 6.83, or 15%, on 4.8 million shares. Celldex Therapeutics, Inc. (CLDX) popped 42 cents to 4.37, or 11%, on 5.1 million shares.

OncoCyte Corporation (OCX) led the way today, up 1.85 to 6.07, or 44%, on low volume. MediciNova Inc. (MNOV) advanced 1.10 to 9.00, or 14%. NantKwest, Inc. (NK) climbed 1.09 to 9.72, or 13%.

Flexion Therapeutics, Inc. (FLXN) ran 1.53 to 10.95, or 16%, on over a half million shares. Momo Inc. (MOMO) had an interesting day, up 1.26 to 12.19, or 11 1/2%, on 4 million shares. Esperion Therapeutics, Inc. (ESPR) thrust 1.86 to 19.36, or 11%.

Edwards Lifesciences Corp. (EW) was big on big earnings, up 15.16 to 105.08, or 17%, on 9 million shares.

Stepping back and reviewing the hourly chart patterns, the indices were down in the morning, up midday, back down in the afternoon, couldn’t rally enough to take back the losses, and ended the day with a weak start to the week.

Let’s see what happens tomorrow.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.